Clinical and uterine cervix characteristics of women with Mycoplasma and Ureaplasma in genital discharge.

Autor:	Matos MS; Bahiana School of Medicine and Public Health, Department of Women's Health - Salvador (BA), Brazil.; Universidade Federal da Bahia, School of Medicine of Bahia, Department of Gynecology and Obstetrics - Salvador (BA), Brazil., Silva MCATD; Bahiana School of Medicine and Public Health, Department of Women's Health - Salvador (BA), Brazil., Brito MB; Bahiana School of Medicine and Public Health, Department of Women's Health - Salvador (BA), Brazil.; Universidade Federal da Bahia, School of Medicine of Bahia, Department of Gynecology and Obstetrics - Salvador (BA), Brazil., Gonçalves AK; Universidade Federal do Rio Grande do Norte, Postgraduate Program in Health Sciences - Natal (RN), Brazil.; Universidade Federal do Rio Grande do Norte, Postgraduate Program in Applied Sciences to Women's Health - Natal (RN), Brazil.; Universidade Federal do Rio Grande do Norte, Department of Gynecology and Obstetrics - Natal (RN), Brazil.
Jazyk:	angličtina
Zdroj:	Revista da Associacao Medica Brasileira (1992) [Rev Assoc Med Bras (1992)] 2024 Jul 19; Vol. 70 (6), pp. e20240045. Date of Electronic Publication: 2024 Jul 19 (Print Publication: 2024).
DOI:	10.1590/1806-9282.20240045
Abstrakt:	Objective: The objective of this study was to assess the clinical and uterine cervix characteristics of patients displaying vaginal discharge with positive results for Mycoplasma sp. and/or Ureaplasma spp. Methods: An analytical cross-sectional study involving women aged 18-45 years was conducted. Microbiological assessments included Ureaplasma and Mycoplasma cultures, as well as human papillomavirus hybrid capture using ecto and endocervix swabs. All tests were two-tailed, and significance was set at p<0.05. Results: Among 324 women, Ureaplasma prevalence was 17.9%, and Mycoplasma prevalence was 3.1%. The Ureaplasma-positive group exhibited a higher frequency of urinary tract infections (39.1 vs. 19%, p=0.002) and human papillomavirus (39.7 vs. 12.8%, p≤0.001) compared with controls. The Mycoplasma-positive group showed a higher frequency of non-contraceptive use compared with controls (66.2 vs. 30.0%, p=0.036). Abnormal colposcopic findings were more prevalent in the Mycoplasma/Ureaplasma-positive group than in controls (positive: 65% vs. control: 35%, p=0.001). Pap smear findings did not differ between the groups. Conclusion: Ureaplasma spp. was associated with urinary tract infections and human papillomavirus, while the presence of Mycoplasma sp. was linked to reduced contraceptive use. When analyzing both pathogens together, a higher frequency of abnormal colposcopic findings was observed, with no difference in cytological findings in the positive group.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu